Publications by authors named "Biaolong Deng"

Claim this Profile
L
Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8T cells.
Biaolong Yang, Biaolong Deng, Xiao-Dong Jiao, Bao-Dong Qin, Yi Lu

Cell Oncol (Dordr)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial.
Xiaofeng Tang, Biaolong Deng, Aiping Zang, Xiaowen He, Ye Zhou

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gallic acid induces T-helper-1-like T cells and strengthens immune checkpoint blockade efficacy.
Biaolong Deng, Biaolong Yang, Jieqiong Chen, Shuaiwei Wang, Weiqi Zhang

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXP3 regulatory T cells and age-related diseases.
Biaolong Deng, Weiqi Zhang, Yicheng Zhu, Yangyang Li, Dan Li

FEBS J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin signaling establishes a developmental trajectory of adipose regulatory T cells.
Yangyang Li, Ying Lu, Shu-Hai Lin, Ning Li, Yichao Han, Biaolong Deng

Nat Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis